Private Equity Investments Support American Health Care & COVID-19 Response

Private equity plays a critical role in supporting quality, affordable health care in the United States. For decades, PE-funded innovations have delivered more effective treatments and saved lives — and, importantly, helped lower health care costs for millions of Americans. According to data compiled by Pitchbook, private equity invested more than $79 billion in U.S. health care throughout 2020 to fund research into deadly diseases like Alzheimer’s and Parkinson’s, expand and renovate facilities, modernize medical records and health care data, and make other needed investments.

This year, private equity firms provided much-needed capital to health care companies and hospitals combatting the COVID-19 pandemic. Private equity investments supported the development of a robust antibody test and helped speed up the processing of COVID-19 tests. The industry also provided capital supporting the doctors and researchers developing vaccines and treatments, and many private equity-backed businesses are providing PPE and other supplies to health care workers on the frontlines.

 

Read about just a few of the recent investments private equity has made in health care:

Protecting Americans from COVID-19

Modernizing Health Care Data and Medical Records

Investing in Hospitals and Health Clinics

Developing in Life-Saving Drugs and Medical Devices

Supporting Frontline Providers

Private equity plays a critical role in supporting quality, affordable health care in the United States. For decades, PE-funded innovations have delivered more effective treatments and saved lives — and, importantly, lowered costs and made health care more accessible for millions of Americans in urban and rural communities.

Read the full document here:

 

Private Equity Health Care